These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8277044)

  • 1. Joint pains with psoriasis and long-term systemic etretinate therapy: a case report and summary of 12 cases.
    Ishida Y; Ozawa A; Ohkido M; Imai N
    J Dermatol; 1993 Oct; 20(10):651-3. PubMed ID: 8277044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study.
    Stern RS; Fitzgerald E; Ellis CN; Lowe N; Goldfarb MT; Baughman RD
    J Am Acad Dermatol; 1995 Jul; 33(1):44-52. PubMed ID: 7601945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etretinate therapy in generalized pustular psoriasis (Zumbusch type). Immediate and long-term results.
    Wolska H; Jabłonska S; Langner A; Fraczykowska M
    Dermatologica; 1985; 171(5):297-304. PubMed ID: 3908171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of etretinate on the liver in psoriasis.
    Camuto P; Shupack J; Orbuch P; Tobias H; Sidhu G; Feiner H
    Am J Surg Pathol; 1987 Jan; 11(1):30-7. PubMed ID: 3789256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etretinate in pustular psoriasis of palms and soles.
    White SI; Marks JM; Shuster S
    Br J Dermatol; 1985 Nov; 113(5):581-5. PubMed ID: 3904810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial liver biopsies in psoriatic patients receiving long-term etretinate.
    Roenigk HH; Gibstine C; Glazer S; Sparberg M; Yokoo H
    Br J Dermatol; 1985 Jan; 112(1):77-81. PubMed ID: 3970836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Skeletal alterations associated with long-term etretinate therapy].
    Okada N; Higashiyama M; Morimoto S; Yoshikawa K
    Nihon Hifuka Gakkai Zasshi; 1991 Apr; 101(5):547-52. PubMed ID: 1890751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density of the lumbar spine in psoriatic patients with long term etretinate therapy.
    Okada N; Nomura M; Morimoto S; Ogihara T; Yoshikawa K
    J Dermatol; 1994 May; 21(5):308-11. PubMed ID: 8051315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of etretinate (RO-10-9359) in intermittent doses and follow-up for 1 year in patients with psoriasis. Final report].
    Domínguez Soto L; Hokyo Tomoka MT; Armas JJ
    Med Cutan Ibero Lat Am; 1984; 12(1):47-56. PubMed ID: 6376979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience with etretinate (Tigason) in 26 patients with psoriasis].
    Gajardo J
    Rev Med Chil; 1989 May; 117(5):516-22. PubMed ID: 2519162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral neuropathy during etretinate therapy for psoriasis.
    Hammer CJ; Carter CC; Hanifin JM
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):272-3. PubMed ID: 8381828
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombocytopenia associated with etretinate therapy.
    Liang R
    Acta Haematol; 1988; 79(2):112-3. PubMed ID: 3124469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate and etretinate in the treatment of psoriasis.
    Vanderveen EE; Ellis CN
    Arch Dermatol; 1984 Dec; 120(12):1555-6. PubMed ID: 6508327
    [No Abstract]   [Full Text] [Related]  

  • 15. Etretinate therapy for psoriasis and other keratinizing disorders: a 10-year retrospective study in Singapore.
    Shahidullah M; Tham SN; Goh CL
    Int J Dermatol; 1993 Sep; 32(9):686-9. PubMed ID: 7691773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation.
    Frati C; Bevilacqua L; Apostolico V
    Acta Derm Venereol Suppl (Stockh); 1994; 186():151-3. PubMed ID: 8073820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term etretinate for pustular psoriasis.
    Rubin MG; Hanno R
    J Am Acad Dermatol; 1985 May; 12(5 Pt 1):896-7. PubMed ID: 4008697
    [No Abstract]   [Full Text] [Related]  

  • 18. PUVA, etretinate, and PUVA-etretinate therapy for pustulosis palmoplantaris. A placebo-controlled comparative trial.
    Rosén K; Mobacken H; Swanbeck G
    Arch Dermatol; 1987 Jul; 123(7):885-9. PubMed ID: 3300565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of oral methoxypsoralen: photochemotherapy (PUVA) and an aromatic retinoid (etretinate, tigason) in the treatment of psoriasis.
    Thirumoorthy T; Tham SN; Tan YC
    J Dermatol; 1986 Apr; 13(2):132-6. PubMed ID: 3531270
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential hepatotoxicity of two oral retinoids (etretinate and isotretinoin) in a patient with palmoplantar psoriasis.
    Vahlquist A; Lööf L; Nordlinder H; Rollman O; Vahlquist C
    Acta Derm Venereol; 1985; 65(4):359-62. PubMed ID: 2413699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.